Press Releases
RMTC Board Amends its List of Controlled Therapeutic Medications in an Effort to Advance…3/18/2014
NEWS RELEASE March 18, 2014 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD AMENDS ITS LIST OF CONTROLLED THERAPEUTIC MEDICATIONS IN AN EFFORT TO ADVANCE THE REFORM MOVEMENT, COMMITS SIGNIFICANT FUNDS TO 2014 TACTICAL RESEARCH
RMTC: Current Threshold Levels for Corticosteroids, Clenbuterol Should Remain 12/3/2013
NEWS RELEASE December 3, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC: CURRENT THRESHOLD LEVELS FOR CORTICOSTEROIDS, CLENBUTEROL SHOULD REMAIN The Racing Medication & Testing Consortium (RMTC) is releasing two position papers which stated that
RMTC Tactical Research Program Identifies Substances in Roberson Case for Delaware Racing…10/17/13
NEWS RELEASE October 17, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC TACTICAL RESEARCH PROGRAM IDENTIFIES SUBSTANCES IN ROBERSON CASE FOR DELAWARE RACING COMMISSION The RMTC Tactical Research Program was instrumental in the Delaware Thoroughbred
RMTC Board: Stanozolol Threshold Eliminated, Ohio Lab Granted Interim Accreditation…9/20/13
NEWS RELEASE September 20, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD: STANOZOLOL THRESHOLD ELIMINATED, OHIO STATE LAB GRANTED INTERIM ACCREDITATION, UNIFORM NATIONAL MEDICATION RULES, PENALTIES AND LAB REFORMS ENDORSED, OUT OF COMPETITION TESTING
RMTC Gives Final Approval for Multiple Violation Penalty Model Rule 7/19/13
NEWS RELEASE July 19, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC GIVES FINAL APPROVAL FOR MULTIPLE VIOLATION PENALTY MODEL RULE The Racing Medication and Testing Consortium (RMTC) board of directors has given final approval
RMTC Issues Drug Bulletins on Purple Pain and TB-500 7/2/13
NEWS RELEASE July 2, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC ISSUES DRUG BULLETINS ON PURPLE PAIN AND TB-500 The Racing Medication and Testing Consortium (RMTC) Tactical Research Committee has reviewed data from laboratory
RMTC Accredits First Two Laboratories 6/13/13
NEWS RELEASE June 13, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC ACCREDITS FIRST TWO LABORATORIES Lexington, KY -- The University of California-Davis Kenneth L. Maddy Laboratory and HFL Sport Science Inc., Lexington, Ky., became
RMTC Approves Multiple Violation Penalty System 6/6/13
NEWS RELEASE June 6, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC APPROVES MULTIPLE VIOLATION PENALTY SYSTEM A new penalty system for North American racing designed to reduce positive drug tests and identify and penalize
RMTC Board Recommends Therapeutic Withdrawal Times, Grants First Interim Lab Accreditation 3/21/13
NEWS RELEASE March 21, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD RECOMMENDS THERAPEUTIC WITHDRAWAL TIMES, GRANTS FIRST INTERIM LAB ACCREDITATION At its March 19 meeting in Baltimore, Maryland, the Racing Medication and Testing
RMTC Reports Overall Decrease in Phenylbutazone Violations in Jurisdictions that Adopted 2…1/25/13
NEWS RELEASE January 25, 2013 Contact: Hallie Lewis (859) 224-2848 RMTC REPORTS OVERALL DECREASE IN PHENYLBUTAZONE VIOLATIONS IN JURISDICTIONS THAT ADOPTED 2 MICROGRAM THRESHOLD A recent Racing Medication and Testing Consortium (RMTC) review of violation
RMTC Board Announces Corticosteroid Withdrawal Recommendations Resulting from its…12/20/12
NEWS RELEASE December 20, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD ANNOUNCES CORTICOSTEROID WITHDRAWAL RECOMMENDATIONS RESULTING FROM ITS CORTICOSTEROID EXPERTS CONFERENCE The Racing Medication and Testing Consortium (RMTC) recently approved minimum withdrawal time recommendations
RMTC Board Makes Therapeutic Withdrawal Recommendations, Announces Upcoming…11/15/12
NEWS RELEASE November 15, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD MAKES THERAPEUTIC WITHDRAWAL RECOMMENDATIONS, ANNOUNCES UPCOMING CORTICOSTEROIDS CONFERENCE At its November 13 meeting in Louisville, Kentucky, the Racing Medication and Testing Consortium (RMTC)
Statement from the Racing Medication and Testing Consortium 8/30/12
NEWS RELEASE August 30, 2012 Contact: Hallie Lewis (859) 224-2848 STATEMENT FROM THE RACING MEDICATION AND TESTING CONSORTIUM The Kentucky Horse Racing Commission recently approved regulations based on the Association of Racing Commissioners International (RCI)
Dr. Dionne Benson Named RMTC Executive Director and COO 7/11/12
NEWS RELEASE July 11, 2012 Contact: Hallie Lewis (859) 224-2848 DR. DIONNE BENSON NAMED RMTC EXECUTIVE DIRECTOR AND COO The Racing Medication and Testing Consortium (RMTC) today announced the hiring of Dr. Dionne Benson as
RMTC Board Names Interim Executive Director, Receives Updates on Drug Administration…04/24/12
NEWS RELEASE April 24, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD NAMES INTERIM EXECUTIVE DIRECTOR, RECEIVES UPDATES ON DRUG ADMINISTRATION STUDIES AND MAKES THRESHOLD LEVEL RECOMMENDATION At its April 23 meeting in Dallas, Texas,
Race Day Medication, Drug Testing Initiatives and Research Committees Provide Updates to…10/10/11
NEWS RELEASE October 10, 2011 Contact: Hallie Lewis (859) 224-2848 or Chris Scherf (410) 392-9200 RACE DAY MEDICATION, DRUG TESTING INITIATIVES AND RESEARCH COMMITTEES PROVIDE UPDATES TO RMTC BOARD At its October 6 meeting in
RMTC Approves New Policy Recommendations Based on Reports from its Race Day Medication… 8/4/11
NEWS RELEASE August 4, 2011 Contact: Hallie Lewis (859) 224-2848 or Chris Scherf (302) 981-6145 RMTC APPROVES NEW POLICY RECOMMENDATIONS BASED ON REPORTS FROM ITS RACE DAY MEDICATION COMMITTEES HEBRON, KY --The Racing Medication and
Racing Medication and Testing Consortium to Hold Special Board Meeting August 4 7/13/11
NEWS RELEASE July 13, 2011 Contact: Rebecca A. Hills (859) 224-2844 RACING MEDICATION AND TESTING CONSORTIUM TO HOLD SPECIAL BOARD MEETING AUGUST 4 The Racing Medication and Testing Consortium (RMTC), which consists of 25 racing
RMTC Joins NTRA and AAEP in Organizing Upcoming International Summit to Address Race Day…4/20/11
NEWS RELEASE April 20, 2011 Contact: Hallie Lewis (859) 224-2848 RMTC JOINS NTRA AND AAEP IN ORGANIZING UPCOMING INTERNATIONAL SUMMIT TO ADDRESS RACE DAY MEDICATION The Racing Medication and Testing Consortium (RMTC) board of directors
RMTC Makes Therapeutic Withdrawal Time Recommendations, Announces Progress of its Drug… 10/20/10
NEWS RELEASE October 20, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC MAKES THERAPEUTIC WITHDRAWAL TIME RECOMMENDATIONS, ANNOUNCES PROGRESS OF ITS DRUG TESTING INITIATIVES TASK FORCE Based on the recommendation of its Scientific Advisory Committee, the
RMTC Eagerly Anticipates NSAID Discussion When RCI Model Rules Committee Convenes in July 6/11/10
NEWS RELEASE June 11, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC EAGERLY ANTICIPATES NSAID DISCUSSION WHEN RCI MODEL RULES COMMITTEE CONVENES IN JULY A recently published report previewing the National Horsemen’s Benevolent and Protective Association
RMTC to Fund Post-Doctoral Research Fellowship for Two Applicants 5/7/10
NEWS RELEASE May 7, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC TO FUND POST-DOCTORAL RESEARCH FELLOWSHIP FOR TWO APPLICANTS The Racing Medication and Testing Consortium (RMTC) board of directors has approved the funding of Dr.
RMTC Recommends New Phenylbutazone Threshold Level, Announces Launch of Recent Rulings… 4/15/10
NEWS RELEASE April 15, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC RECOMMENDS NEW PHENYLBUTAZONE THRESHOLD LEVEL, ANNOUNCES LAUNCH OF RECENT RULINGS DATABASE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and
RMTC Seeks Director of Research 3/4/10
NEWS RELEASE March 4, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC SEEKS DIRECTOR OF RESEARCH The Racing Medication and Testing Consortium (RMTC) is seeking applications for the position of Director of Research. The individual holding
RMTC Board Forms Committee to Oversee Implementation of DTI Task Force Recommendations 10/1/09
NEWS RELEASE October 1, 2009 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD FORMS COMMITTEE TO OVERSEE IMPLEMENTATION OF DTI TASK FORCE RECOMMENDATIONS Moving forward with its initiative to significantly change the structure of drug testing